Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Comparison of hypertension remission and relapse after sleeve gastrectomy and one-anastomosis gastric bypass: a prospective cohort study

Abstract

This study aimed to assess the remission and relapse of hypertension (HTN) in hypertensive individuals who underwent sleeve gastrectomy (SG) and one-anastomosis gastric bypass (OAGB) and identify the predictors of HTN remission and relapse following bariatric surgery. A prospective cohort study with a follow-up of 3 years was conducted on severely obese patients between 2013 and 2018. Hypertension remission was defined as the normalization of blood pressure (BP) with the discontinuation of medical treatment, and HTN relapse was defined as the need for the onset of antihypertensive drugs or the occurrence of BP impairment. A total of 787 hypertensive patients were included in this study. The cumulative incidence of HTN remission and relapse were 83.9% (95% CI: 81.6–86.5) and 31.4% (95% CI: 25.6–38.2), respectively. Remission and relapse were not significantly different among the patients undergoing either surgery (SG or OAGB). A higher remission rate was linked to a younger age and the use of fewer antihypertensive medications pre-operation. However, failure to successfully lose weight during the first year postoperative and weight regain predicted a higher risk of HTN relapse after 3 years. Following bariatric surgery, BP drops initially but then gradually rises. These alterations are responsible for about 31% relapse after 3 years in those who initially achieve remission. Patients who are younger and use less antihypertensive medications before surgery may benefit the most from bariatric surgery in terms of HTN. First-year successful weight loss and control of weight regain may prevent HTN relapse in the following years.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The datasets used and analyzed in the current study are available from the corresponding author on reasonable request.

References

  1. Stevens G, Mascarenhas M, Mathers C. Global health risks: progress and challenges. Bull World Health Organ. 2009;87:646.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23.

    Article  PubMed  Google Scholar 

  3. Sarki AM, Nduka CU, Stranges S, Kandala NB, Uthman OA. Prevalence of hypertension in low- and middle-income countries: a systematic review and meta-analysis. Medicine. 2015;94:e1959.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Yusufali AM, Khatib R, Islam S, Alhabib KF, Bahonar A, Swidan HM, et al. Prevalence, awareness, treatment and control of hypertension in four Middle East countries. J Hypertens. 2017;35:1457–64.

    Article  CAS  PubMed  Google Scholar 

  5. Afsargharehbagh R, Rezaie-Keikhaie K, Rafiemanesh H, Balouchi A, Bouya S, Dehghan B. Hypertension and pre-hypertension among Iranian adults population: a meta-analysis of prevalence, awareness, treatment, and control. Curr Hypertens Rep. 2019;21:27.

    Article  PubMed  Google Scholar 

  6. Garrison RJ, Kannel WB, Stokes J 3rd, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med. 1987;16:235–51.

    Article  CAS  PubMed  Google Scholar 

  7. Hall ME, do Carmo JM, da Silva AA, Juncos LA, Wang Z, Hall JE. Obesity, hypertension, and chronic kidney disease. Int J Nephrol Renov Dis. 2014;7:75–88.

    Article  Google Scholar 

  8. Cohen JB. Hypertension in obesity and the impact of weight loss. Curr Cardiol Rep. 2017;19:98.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity, kidney dysfunction and hypertension: mechanistic links. Nat Rev Nephrol. 2019;15:367–85.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Severin R, Sabbahi A, Mahmoud AM, Arena R, Phillips SA. Precision medicine in weight loss and healthy living. Prog Cardiovasc Dis. 2019;62:15–20.

    Article  PubMed  PubMed Central  Google Scholar 

  11. English WJ, Williams DB. Metabolic and bariatric surgery: an effective treatment option for obesity and cardiovascular disease. Prog Cardiovasc Dis. 2018;61:253–69.

    Article  PubMed  Google Scholar 

  12. Wiggins T, Guidozzi N, Welbourn R, Ahmed AR, Markar SR. Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level: a systematic review and meta-analysis. PLoS Med. 2020;17:e1003206.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Angrisani L, Santonicola A, Iovino P, Vitiello A, Higa K, Himpens J, et al. IFSO Worldwide Survey 2016: primary, endoluminal, and revisional procedures. Obes Surg. 2018;28:3783–94.

    Article  PubMed  Google Scholar 

  14. Climent E, Goday A, Pedro-Botet J, Solà I, Oliveras A, Ramón JM, et al. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for 5-year hypertension remission in obese patients: a systematic review and meta-analysis. J Hypertens. 2020;38:185–95.

    Article  CAS  PubMed  Google Scholar 

  15. Vest AR, Heneghan HM, Agarwal S, Schauer PR, Young JB. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98:1763–77.

    Article  PubMed  Google Scholar 

  16. Benaiges D, Sagué M, Flores-Le Roux JA, Pedro-Botet J, Ramón JM, Villatoro M, et al. Predictors of hypertension remission and recurrence after bariatric surgery. Am J Hypertens. 2016;29:653–9.

    Article  CAS  PubMed  Google Scholar 

  17. Nudotor RD, Canner JK, Haut ER, Prokopowicz GP, Steele KE. Comparing remission and recurrence of hypertension after bariatric surgery: vertical sleeve gastrectomy versus Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2021;17:308–18.

    Article  CAS  PubMed  Google Scholar 

  18. Reynolds K, Barton LJ, Basu A, Fischer H, Arterburn DE, Barthold D, et al. Comparative effectiveness of gastric bypass and vertical sleeve gastrectomy for hypertension remission and relapse: the ENGAGE CVD Study. Hypertension. 2021;78:1116–25.

    Article  CAS  PubMed  Google Scholar 

  19. Stenberg E, Marsk R. Remission, relapse, and risk of major cardiovascular events after metabolic surgery in persons with hypertension: a Swedish nationwide registry-based cohort study. PLoS Med. 2021;18:e1003817.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Barzin M, Hosseinpanah F, Motamedi MA, Shapoori P, Arian P, Daneshpour MA, et al. Bariatric surgery for morbid obesity: Tehran Obesity Treatment Study (TOTS) rationale and study design. JMIR Res Protoc. 2016;5:e8.

    Article  PubMed  PubMed Central  Google Scholar 

  21. de Onis M, Habicht JP. Anthropometric reference data for international use: recommendations from a World Health Organization Expert Committee. Am J Clin Nutr. 1996;64:650–8.

    Article  PubMed  Google Scholar 

  22. Brethauer SA, Kim J, el Chaar M, Papasavas P, Eisenberg D, Rogers A, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surgery for obesity and related diseases: official journal of the American Society for Bariatric. Surgery. 2015;11:489–506.

    Google Scholar 

  23. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2018;138:e426–83.

    PubMed  Google Scholar 

  24. Livhits M, Mercado C, Yermilov I, Parikh JA, Dutson E, Mehran A, et al. Preoperative predictors of weight loss following bariatric surgery: systematic review. Obes Surg. 2012;22:70–89.

    Article  PubMed  Google Scholar 

  25. King WC, Hinerman AS, Courcoulas AP. Weight regain after bariatric surgery: a systematic literature review and comparison across studies using a large reference sample. Surg Obes Relat Dis. 2020;16:1133–44.

    Article  PubMed  Google Scholar 

  26. Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020;324:879–87.

    Article  PubMed  Google Scholar 

  27. Ebadinejad A, Barzin M, Abiri B, Mahdavi M, Khalaj A, Ebrahimi D, et al. The effect of bariatric surgery in comparison with the control group on the prevention of comorbidities in people with severe obesity: a prospective cohort study. BMC Surg. 2022;22:290.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Khalaj A, Tasdighi E, Hosseinpanah F, Mahdavi M, Valizadeh M, Farahmand E, et al. Two-year outcomes of sleeve gastrectomy versus gastric bypass: first report based on Tehran obesity treatment study (TOTS). BMC Surg. 2020;20:160.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Wu C, Bai R, Yan W, Yan M, Song M. Clinical outcomes of one anastomosis gastric bypass versus sleeve gastrectomy for morbid obesity. Obes Surg. 2020;30:1021–31.

    Article  PubMed  Google Scholar 

  30. Schiavon CA, Bhatt DL, Ikeoka D, Santucci EV, Santos RN, Damiani LP, et al. Three-year outcomes of bariatric surgery in patients with obesity and hypertension: a randomized clinical trial. Ann Intern Med. 2020;173:685–93.

    Article  PubMed  Google Scholar 

  31. Climent E, Oliveras A, Pedro-Botet J, Goday A, Benaiges D. Bariatric surgery and hypertension. J Clin Med. 2021;10:4049.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Moriconi D, Manca ML, Anselmino M, Rebelos E, Bellini R, Taddei S, et al. Predictors of type 2 diabetes relapse after Roux-en-Y gastric bypass: a ten-year follow-up study. Diabetes Metab. 2022;48:101282.

    Article  CAS  PubMed  Google Scholar 

  33. Rebelos E, Moriconi D, Scalese M, Denoth F, Molinaro S, Siciliano V, et al. Impact of postprandial hypoglycemia on weight loss after bariatric surgery. Obes Surg. 2020;30:2266–73.

    Article  PubMed  Google Scholar 

  34. Rezaei S, Mahmoudi Z, Sheidaei A, Aryan Z, Mahmoudi N, Gohari K, et al. Salt intake among Iranian population: the first national report on salt intake in Iran. J Hypertens. 2018;36:2380–9.

    Article  CAS  PubMed  Google Scholar 

  35. Hall ME, Cohen JB, Ard JD, Egan BM, Hall JE, Lavie CJ, et al. Weight-loss strategies for prevention and treatment of hypertension: a scientific statement from the American Heart Association. Hypertension. 2021;78:e38–50.

    Article  CAS  PubMed  Google Scholar 

  36. Samson R, Ayinapudi K, Le Jemtel TH, Oparil S. Obesity, hypertension, and bariatric surgery. Curr Hypertens Rep. 2020;22:46.

    Article  CAS  PubMed  Google Scholar 

  37. le Roux CW, Welbourn R, Werling M, Osborne A, Kokkinos A, Laurenius A, et al. Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg. 2007;246:780–5.

    Article  PubMed  Google Scholar 

  38. Sandoval DA, D’Alessio DA. Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease. Physiol Rev. 2015;95:513–48.

    Article  CAS  PubMed  Google Scholar 

  39. Bonfils PK, Taskiran M, Damgaard M, Goetze JP, Floyd AK, Funch-Jensen P, et al. Roux-en-Y gastric bypass alleviates hypertension and is associated with an increase in mid-regional pro-atrial natriuretic peptide in morbid obese patients. J Hypertens. 2015;33:1215–25.

    Article  CAS  PubMed  Google Scholar 

  40. Landsberg L, Aronne LJ, Beilin LJ, Burke V, Igel LI, Lloyd-Jones D, et al. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment—a position paper of the The Obesity Society and The American Society of Hypertension. Obesity. 2013;21:8–24.

  41. Petersen KS, Blanch N, Keogh JB, Clifton PM. Effect of weight loss on pulse wave velocity: systematic review and meta-analysis. Arterioscler Thromb Vasc Biol. 2015;35:243–52.

    Article  CAS  PubMed  Google Scholar 

  42. Moritz E, Dadson P, Saukko E, Honka MJ, Koskensalo K, Seppälä K, et al. Renal sinus fat is expanded in patients with obesity and/or hypertension and reduced by bariatric surgery associated with hypertension remission. Metabolites. 2022;12:617.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Agha R, Abdall-Razak A, Crossley E, Dowlut N, Iosifidis C, Mathew G. STROCSS 2019 guideline: strengthening the reporting of cohort studies in surgery. Int J Surg. 2019;72:156–65.

    Article  PubMed  Google Scholar 

  44. Sjöström CD, Peltonen M, Wedel H, Sjöström L. Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension. 2000;36:20–5.

    Article  PubMed  Google Scholar 

  45. O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731–68.

    Article  PubMed  Google Scholar 

  46. Kotsis V, Stabouli S, Bouldin M, Low A, Toumanidis S, Zakopoulos N. Impact of obesity on 24-hour ambulatory blood pressure and hypertension. Hypertension. 2005;45:602–7.

    Article  CAS  PubMed  Google Scholar 

  47. Oliveras A, Goday A, Sans L, Arias CE, Vazquez S, Benaiges D, et al. Changes in central 24-h ambulatory blood pressure and hemodynamics 12 months after bariatric surgery: the BARIHTA study. Obes Surg. 2020;30:195–205.

    Article  PubMed  Google Scholar 

  48. Vidal J, Nicolau J, Romero F, Casamitjana R, Momblan D, Conget I, et al. Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects. J Clin Endocrinol Metab. 2009;94:884–91.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank the hospital staff, assistants, and coordinators who took part in this research. Also, special thanks to Mohammadreza Golsibi for his assistance and support in working with the electronic patient data system.

Author information

Authors and Affiliations

Authors

Contributions

AE: study design, data collection, coordination of patients’ issues, manuscript preparation, and final approval of the manuscript. MS: data collection, literature review, and manuscript preparation. FH: data collection, literature review, and manuscript preparation. AK: study design, performing surgical operations, and final approval of the manuscript. MM: data analysis, data interpretation, and manuscript preparation. FG: data collection, literature review, and manuscript preparation. MV: final approval of the manuscript. MB: study design, revising the manuscript, and final approval of the manuscript. All authors reviewed and approved the final draft of the manuscript.

Corresponding author

Correspondence to Maryam Barzin.

Ethics declarations

Ethics approval and consent to participate

All the procedures performed in the study were approved by the Research Ethics Committee of the Research Institute for Endocrine Sciences of Shahid Beheshti University of Medical Sciences and were in accordance with the ethical standards of the institutional Human Research Review Committee (IR.SBMU.ENDOCRINE.REC.1400.096) and the 1964 Helsinki declaration and its later amendments. Informed written consent was obtained from all participants.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ebadinejad, A., Shahshahani, M., Hosseinpanah, F. et al. Comparison of hypertension remission and relapse after sleeve gastrectomy and one-anastomosis gastric bypass: a prospective cohort study. Hypertens Res 46, 1287–1296 (2023). https://doi.org/10.1038/s41440-023-01180-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41440-023-01180-7

Keywords

This article is cited by

Search

Quick links